Unraveling the Conundrums of Running Royalties in Cross-Border Patent License Agreements
les Nouvelles - Journal of the Licensing Executives Society, Volume LII No. 1, March 2017
8 Pages Posted: 4 Mar 2017 Last revised: 6 Jun 2017
Date Written: February 13, 2017
Adjacent to the glorious and delicate stained glass of Sainte-Chapelle, stands the magnificent “Palace of Justice,” currently housing the Court of Appeal of Paris. In Genentech v. Hoechst, the court encountered an enigma involving patent royalties and European competition law. A license agreement licensed three patents. One patent was subsequently revoked. The other two patents were later found not to be infringed by the licensee. Yet, the license agreement imposed an obligation on the licensee to pay running royalties throughout the contractual term. Is the imposition of this obligation permitted under Article 101 of the Treaty on the Functioning of the European Union?
The Court of Appeal of Paris referred this question to the Court of Justice of the European Union. On July 7, 2016, the Court of Justice of the European Union issued a judgment answering the question in the affirmative.
Analyzing the judgment in comparison with legal precedent in the United States such as Kimble v. Marvel Entertainment evinces differing judicial approaches to interpreting license agreements and discerning the parties’ commercial intent when royalty payments and patent monopoly are at issue. Similar cases in the United States, France, and Japan provide practical guidance concerning the licensees’ obligation to pay royalties and whether licensees are entitled to a refund when the licensed patents are ultimately invalidated.
Keywords: Sainte-Chapelle, Palace of Justice, Paris, Genetech v. Hoechst, European law, European Union, Kimble v. Marvel Entertainment, royalty payments
Suggested Citation: Suggested Citation